Eye Care Professional Education is ranked #39 of 46 education organizations in Las Vegas, NV, with an America's Best Score of 63 out of 100, based on its 2024 Form 990.
Eye Care Professional Education is a 501(c)(3) organization, classified under Education (NTEE B90). Contributions are tax-deductible.
9260 W Sunset Rd, Las Vegas, NV 89148-4858
Among the 89 scored education organizations in Las Vegas, Eye Care Professional Education holds 1.7 months of operating reserves (peer median 8.5 months), runs a typical yearly surplus of 6.9% (peers: surplus of 6.8%), and has grown spending 26.9% a year (peers: grown spending 11.4% a year).
In fiscal year 2024 it reported $801,916 in revenue and $750,431 in expenses, with contributions making up 66.2% of revenue.
Eye Care Professional Education inc is a 501-c3 non profit organization committed to provided high quality education to eye care practitioners residents and students all over the world. Many students and physicians are unable to travel for education which is why our organization develops high quality virtual events. Our events are mostly virtual which enables eye care professionals from anywhere to access highly requested topics presented by experts in the eye care field.
Largest programs · fiscal year 2024
DRY EYE IN THE DESERT This hybrid educational event focuses exclusively on the critical topic of dry eye disease management. Through unique courses and a distinguished panel of industry-leading experts Dry Eye in the Desert educates eye care professionals ECPs on the latest diagnostics and therapeutic strategies. In-person attendees benefit from hands-on skills transfers live presentations and foc… Read more
DRY EYE IN THE DESERT This hybrid educational event focuses exclusively on the critical topic of dry eye disease management. Through unique courses and a distinguished panel of industry-leading experts Dry Eye in the Desert educates eye care professionals ECPs on the latest diagnostics and therapeutic strategies. In-person attendees benefit from hands-on skills transfers live presentations and focused interactions with industry sponsors in a dedicated exhibit hall directly contributing to the immediate improvement of clinical practices within the dry eye arena.
$16,846 spent · 2.6% of program spending
Glaukos ILINK AND COE Keratoconus characterized by the thinning and bulging of the cornea requires precise diagnosis and timely intervention to ensure effective management and improved patient outcomes. The Glaukos Centers of Excellence COE and iLink Users Group ILUG were designed to build advanced knowledge and expertise among practicioners performing corneal cross-linking for Keratoconus patient… Read more
Glaukos ILINK AND COE Keratoconus characterized by the thinning and bulging of the cornea requires precise diagnosis and timely intervention to ensure effective management and improved patient outcomes. The Glaukos Centers of Excellence COE and iLink Users Group ILUG were designed to build advanced knowledge and expertise among practicioners performing corneal cross-linking for Keratoconus patients. This program focuses on in-depth training and resources that empower doctors to deliver exceptional care particularly for complex keratoconus cases. By enhancing doctor proficiency and confidence in this critical treatment the ILUG and COE programs help bring corneal cross-linking into broader practice allowing more
$15,784 spent · 2.5% of program spending
ORAL PHARMACEUTICALS This program delivers a comprehensive interactive curriculum designed to significantly enhance the clinical knowledge of eye care professionals regarding the safe and effective use of oral and systemic pharmacological agents within a primary care optometric practice. The course series provides an in-depth examination of appropriate oral pharmaceutical management for a wide var… Read more
ORAL PHARMACEUTICALS This program delivers a comprehensive interactive curriculum designed to significantly enhance the clinical knowledge of eye care professionals regarding the safe and effective use of oral and systemic pharmacological agents within a primary care optometric practice. The course series provides an in-depth examination of appropriate oral pharmaceutical management for a wide variety of anterior segment and ocular surface diseases including infections inflammatory conditions and special populations such as pediatric patients. The program emphasizes practical clinical application discussing critical information such as systemic dosing identification of adverse allergic reactions use during pregnancy and the crucial evolving landscape of pharmacological agents.
$30,000 spent · 4.7% of program spending
This not- for- profit hosts many other smaller programs throughout the year bringing in knowledgeable speakers and providing exceptional education in many different topics.$576,411 spent · 90.2% of program spending
Loan from interested person loan was paid in full - no loan after 2024
Where each dollar went · fiscal year 2024
Of every dollar it spent, 85¢ went to programs, 15¢ to management and 0¢ to fundraising.
Programs $639,041
Management $111,391
Fundraising $0
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Spending on programs Not scored; America's Best needs 65%+
85%
Meets
Compared with Las Vegas peers
Measure
This organization
Peer median
Operating reserves
1.7 mo
8.5 mo
Typical margin
+6.9%
+6.8%
Spending growth
+26.9% / yr
+11.4% / yr
Debt load
25.0%
6.5%
Peers: the 89 Las Vegas education organizations with a score, ranked or below the bar.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$801,916Fiscal year 2024
Expenses$750,431Fiscal year 2024
Total assets$141,384Fiscal year 2024
Total liabilities$35,318Fiscal year 2024
Fiscal year ending December2024
Revenue$801,916
Expenses$750,431
Net income$51,485
Net assets$106,066
Notable sources of revenue
Percent of total revenue
Contributions
$530,584
66.2%
Program services
$271,332
33.8%
Investment income
$0
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$141,384
Total liabilities
$35,318
Net assets
$106,066
Compensation
Not in our extract for this year.
Fiscal year ending December2023
Revenue$635,869
Expenses$593,016
Net income$42,853
Net assets$54,581
Notable sources of revenue
Percent of total revenue
Contributions
$98,328
15.5%
Program services
$537,541
84.5%
Investment income
$0
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$81,482
Total liabilities
$26,901
Net assets
$54,581
Compensation
Officers and key employees
$75,680
Share of expenses
12.8%
Fiscal year ending December2022
Revenue$467,826
Expenses$465,777
Net income$2,049
Net assets$11,728
Notable sources of revenue
Percent of total revenue
Contributions
$307,390
65.7%
Program services
$160,436
34.3%
Investment income
$0
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$42,912
Total liabilities
$31,184
Net assets
$11,728
Compensation
Officers and key employees
$89,450
Share of expenses
19.2%
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?